Stock listing
Dis-chem Pharmacies Limited
Selected listing: DCP · JSE · ZAC · ZA
Dis-chem Pharmacies Limited (JSE:DCP), Retail Trade. Latest release May 29, 2026: DCP: Revenue up 9.3% to R42.8bn; digital investment impacts HEPS, but cash…
- Ticker
- JSE:DCP
- Asset type
- Stock
- Sector
- Retail Trade
- Industry
- Drugstore Chains
- Exchange
- JSE
- Currency
- ZAC
About Dis-chem Pharmacies Limited
The company is known for its retail pharmacy services and health-related products. Dis-chem is committed to providing quality healthcare solutions to its customers across the region.
Latest news from Dis-chem Pharmacies Limited
DCP: Revenue up 9.3% to R42.8bn; digital investment impacts HEPS, but cash flow and market share rise
May 29, 2026
Dis-Chem Pharmacies Reports Group Revenue For Period 1 September 2025 To 16 February 2026 Increases By 10.1%
February 20, 2026
Dis-Chem Pharmacies Announces Founder Ivan Saltzman To Retire As Executive Director In 2026
December 5, 2025
Dis-Chem Pharmacies Says Allan Gray Clients Now Hold 10.0142% Interest In Company
December 3, 2025
DCP: Core retail profit up 25.8% and revenue up 8.7%, driven by digital and healthcare investments
October 30, 2025
Research Dis-chem Pharmacies Limited
Dis-chem Pharmacies Limited company profile
View the public company page for Dis-chem Pharmacies Limited on 6ix.
Dis-chem Pharmacies Limited news
Read company news and market updates connected to Dis-chem Pharmacies Limited.
Dis-chem Pharmacies Limited investor events
Find investor webinars, events, and replay context for Dis-chem Pharmacies Limited.